Mathematical modelling of in situ and in vitro efflux of ciprofloxacin and grepafloxacin

International Journal of Pharmaceutics

Volumn 307, Issue 1, 2006, Pages 33-41

  Rodriguez Ibanez M ^a   Sanchez Castano G ^a   Montalar Montero, M ^a   Garrigues, T M ^a   Bermejo, M ^a   Merino, V ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Absorption; Caco 2 model; Efflux; Fluoroquinolones; Intestinal permeability; Kinetic modelling

Indexed keywords

CIPROFLOXACIN; GLYCOPROTEIN P; GREPAFLOXACIN; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG DIFFUSION; DRUG MECHANISM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; RAT; VELOCITY;

ANIMALS; ANTI-INFECTIVE AGENTS; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CIPROFLOXACIN; DIFFUSION; FLUOROQUINOLONES; HUMANS; INTESTINAL ABSORPTION; INTESTINE, SMALL; MALE; MODELS, BIOLOGICAL; PERFUSION; PIPERAZINES; RATS; RATS, WISTAR;

EID: 28844438061     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.09.014     Document Type: Article

References (40)

1. M. Bermejo, V. Merino, T.M. Garrigues, J.M. Pla Delfina, A. Mulet, P. Vizet, G. Trouiller, and C. Mercier Validation of a biophysical drug absorption model by the PATQSAR system J. Pharm. Sci. 88 1999 398 405
2. M.E. Cavet, M. West, and N.L. Simmons Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells Br. J. Pharmacol. 121 1997 1567 1578
3. S. Dautrey, K. Felice, A. Petiet, B. Lacour, C. Carbon, and R. Farinotti Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates Br. J. Pharmacol. 127 1999 1728 1734
4. J.T. Doluisio, G.H. Tan, N.F. Billups, and L. Diamond Drug absorption. II. Effect of fasting on intestinal drug absorption J. Pharm. Sci. 58 1969 1200 1202
5. J.T. Doluisio, W.G. Crouthamel, G.H. Tan, J.V. Swintosky, and L.W. Dittert Drug absorption. 3. Effect of membrane storage on the kinetics of drug absorption J. Pharm. Sci. 59 1970 72 76
6. S. Doppenschmitt, H. Spahn-Langguth, C.G. Regardh, and P. Langguth Role of P-glycoprotein-mediated secretion in absorptive drug permeability: an approach using passive membrane permeability and affinity to P-glycoprotein J. Pharm. Sci. 88 1999 1067 1072
7. C. Efthymiopoulos Pharmacokinetics of grepafloxacin J. Antimicrob. Chemother. 40 1997 35 43
8. C. Efthymiopoulos, S.L. Bramer, and A. Maroli Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males Clin. Pharmacokinet. 33 1997 1 8
9. Y. Emi, D. Tsunashima, K. Ogawara, K. Higaki, and T. Kimura Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine J. Pharm. Sci. 87 1998 295 299
10. G. Fricker, J. Drewe, J. Huwyler, H. Gutmann, and C. Beglinger Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation Br. J. Pharmacol. 118 1996 1841 1847
11. N.M. Griffiths, B.H. Hirst, and N.L. Simmons Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? J. Pharmacol. Exp. Ther. 269 1994 496 502
12. M. Hu, J. Chen, D. Tran, Y. Zhu, and G. Leonardo The Caco-2 cell monolayers as an intestinal metabolism model: metabolism of dipeptide Phe-Pro J. Drug Target. 2 1994 79 89
13. M. Hu, J. Chen, Y. Zhu, A.H. Dantzig, R.E. Stratford Jr., and M.T. Kuhfeld Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2) Pharm. Res. 11 1994 1405 1413
14. J. Hunter, B.H. Hirst, and N.L. Simmons Epithelial secretion of vinblastine by human intestinal adenocarcinoma cell (HCT-8 and T84) layers expressing P-glycoprotein Br. J. Cancer 64 1991 437 444
15. J. Hunter, B.H. Hirst, and N.L. Simmons Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers Pharm. Res. 10 1993 743 749
16. T.T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 16 1995 351 380
17. K.A. Lentz, J.W. Polli, S.A. Wring, J.E. Humphreys, and J.E. Polli Influence of passive permeability on apparent P-glycoprotein kinetics Pharm. Res. 17 2000 1456 1460
18. J.T. Lettieri, M.C. Rogge, L. Kaiser, R.M. Echols, and A.H. Heller Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses Antimicrob. Agents Chemother. 36 1992 993 996
19. S. Lowes, and N.L. Simmons Multiple pathways for fluoroquinolone secretion by human intestinal epithelial (Caco-2) cells Br. J. Pharmacol. 135 2002 1263 1275
20. R.V. Martin-Algarra, R.M. Pascual-Costa, M. Merino, and V.G. Casabo Effects of surfactants on amiodarone intestinal absorption. I. Sodium laurylsulfate Pharm. Res. 11 1994 1042 1047
21. A. Martin-Villodre, J.M. Pla-Delfina, J. Moreno, D. Perez-Buendia, J. Miralles, E.F. Collado, E. Sanchez-Moyano, and A. del Pozo Studies on the reliability of a bihyperbolic functional absorption model. I. Ring-substituted anilines J. Pharmacokinet. Biopharm. 14 1986 615 633
22. M. Merino, J.E. Peris-Ribera, F. Torres-Molina, A. Sanchez-Pico, M.C. Garcia-Carbonell, V.G. Casabo, A. Martin-Villodre, and J.M. Pla-Delfina Evidence of a specialized transport mechanism for the intestinal absorption of baclofen Biopharm. Drug Dispos. 10 1989 279 297
23. V. Merino, J. Freixas, M. del Val Bermejo, T.M. Garrigues, J. Moreno, and J.M. Pla-Delfina Biophysical models as an approach to study passive absorption in drug development: 6-fluoroquinolones J. Pharm. Sci. 84 1995 777 782
24. A.D. Mottino, T. Hoffman, L. Jennes, and M. Vore Expression and localization of multidrug resistant protein mrp2 in rat small intestine J. Pharmacol. Exp. Ther. 293 2000 717 723
25. K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats Antimicrob. Agents Chemother. 46 2002 344 349
26. A. Polache, J.M. Pla-Delfina, and M. Merino Partially competitive inhibition of intestinal baclofen absorption by beta-alanine, a nonessential dietary aminoacid Biopharm. Drug Dispos. 12 1991 647 660
27. J. Ramon, S. Dautrey, R. Farinoti, C. Carbon, and E. Rubinstein Intestinal elimination of ciprofloxacin in rabbits Antimicrob. Agents Chemother. 38 1994 757 760
28. M. Rodriguez-Ibanez, R. Nalda-Molina, M. Montalar-Montero, M.V. Bermejo, V. Merino, and T.M. Garrigues Transintestinal secretion of ciprofloxacin, grepafloxacin and sparfloxacin: in vitro and in situ inhibition studies Eur. J. Pharm. Biopharm. 55 2003 241 246
29. E. Rubinstein, L. St Julien, J. Ramon, S. Dautrey, R. Farinotti, J.F. Huneau, and C. Carbon The intestinal elimination of ciprofloxacin in the rat J. Infect. Dis. 169 1994 218 221
30. N. Ruiz-Balaguer, A. Nacher, V.G. Casabo, and M. Merino Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats Antimicrob. Agents Chemother. 41 1997 445 448
31. H. Saitoh, and B.J. Aungst Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine Pharm. Res. 12 1995 1304 1310
32. G. Sanchez-Castano, A. Ruiz-Garcia, N. Banon, M. Bermejo, V. Merino, J. Freixas, T.M. Garrigues, and J.M. Pla-Delfina Intrinsic absolute bioavailability prediction in rats based on in situ absorption rate constants and/or in vitro partition coefficients: 6-fluoroquinolones J. Pharm. Sci. 89 2000 1395 1403
33. R.H. Stephens, C.A. O'Neill, A. Warhurst, G.L. Carlson, M. Rowland, and G. Warhurst Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia J. Pharmacol. Exp. Ther. 296 2001 584 591
34. B.H. Stewart, O.H. Chan, R.H. Lu, E.L. Reyner, H.L. Schmid, H.W. Hamilton, B.A. Steinbaugh, and M.D. Taylor Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans Pharm. Res. 12 1995 693 699
35. T.A. Tartaglione, A.C. Raffalovich, W.J. Poynor, A. Espinel-Ingroff, and T.M. Kerkering Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses Antimicrob. Agents Chemother. 29 1986 62 66
36. A.L. Ungell, S. Nylander, S. Bergstrand, A. Sjoberg, and H. Lennernas Membrane transport of drugs in different regions of the intestinal tract of the rat J. Pharm. Sci. 87 1998 360 366
37. B. Valenzuela, A. Nacher, V.G. Casabo, and A. Martin-Villodre The influence of active secretion processes on intestinal absorption of salbutamol in the rat Eur. J. Pharm. Biopharm. 52 2001 31 37
38. J. Van Asperen, O. Van Tellingen, and J.H. Beijnen The pharmacological role of P-glycoprotein in the intestinal epithelium Pharmacol. Res. 37 1998 429 435
39. H. Yamaguchi, I. Yano, Y. Hashimoto, and K.I. Inui Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2 J. Pharmacol. Exp. Ther. 295 2000 360 366
40. H. Yamaguchi, I. Yano, H. Saito, and K. Inui Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo J. Pharmacol. Exp. Ther. 300 2002 1063 1069